GT005
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GT005, covering 2024-03-22 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD [Phase 1, Phase 2]